P
Ping Sun
Publications - 2
Citations - 207
Ping Sun is an academic researcher. The author has contributed to research in topics: Soft tissue & Synovial sarcoma. The author has an hindex of 2, co-authored 2 publications receiving 108 citations.
Papers
More filters
Journal ArticleDOI
Safety and Efficacy of Anlotinib, a Multikinase Angiogenesis Inhibitor, in Patients with Refractory Metastatic Soft-Tissue Sarcoma.
Yihebali Chi,Zhiwei Fang,Xiaonan Hong,Yang Yao,Ping Sun,Guowen Wang,Feng Du,Yongkun Sun,Q. Wu,Guofan Qu,Shusen Wang,Jianmin Song,Jian-Chun Yu,Yongkui Lu,Xia Zhu,Xiaohui Niu,Zhiyong He,Jinwan Wang,Hao Yu,Jianqiang Cai +19 more
TL;DR: Anlotinib showed antitumor activity in several STS entities and the toxicity was manageable, and the most common clinically significant grade 3 or higher adverse events were hypertension, triglyceride elevation, and pneumothorax.
Journal ArticleDOI
Phase II study of anlotinib for treatment of advanced soft tissues sarcomas.
Yihebali Chi,Y. Sun,Jianqiang Cai,Yang Yao,Xiaonan Hong,Zhiwei Fang,Ping Sun,Guowen Wang,Q. Wu,Guofan Qu,Shusen Wang,Jianmin Song,Jian-Chun Yu,Yongkui Lu,Xia Zhu,Xiaohui Niu,Zhiyong He +16 more
TL;DR: No standard therapies are available in China for Soft tissues sarcomas patients who failed to chemotherapies and Anlotinib is a multi-target RTK inhibitor with VEGFR1/2/3, FGFR1...